{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:15:13Z","timestamp":1788952513136,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["217677"],"award-info":[{"award-number":["217677"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["235057"],"award-info":[{"award-number":["235057"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2023-01407"],"award-info":[{"award-number":["2023-01407"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009527","name":"Myndigheten f\u00f6r Samh\u00e4llsskydd och Beredskap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007294","name":"Swedish Civil Contingencies Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.etap.2026.105022","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:33:22Z","timestamp":1776011602000},"page":"105022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro metabolomics for the characterization of drugs of abuse and new psychoactive substances in SH-SY5Y cells"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9959-398X","authenticated-orcid":false,"given":"Manuela Carla","family":"Monti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6712-652X","authenticated-orcid":false,"given":"Darta","family":"Stalberga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-5728","authenticated-orcid":false,"given":"Henrik","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3320-1461","authenticated-orcid":false,"given":"Liam J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8053-3100","authenticated-orcid":false,"given":"Albert","family":"Elmsj\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2026.105022_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152503","article-title":"Effect of temperature on 3,4-Methylenedioxypyrovalerone (MDPV)-induced metabolome disruption in primary mouse hepatic cells","volume":"441","author":"Ara\u00fajo","year":"2020","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/j.etap.2026.105022_bib2","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1007\/s00204-018-2314-9","article-title":"GC\u2013MS metabolomics reveals disturbed metabolic pathways in primary mouse hepatocytes exposed to subtoxic levels of 3,4-methylenedioxymethamphetamine (MDMA)","volume":"92","author":"Ara\u00fajo","year":"2018","journal-title":"Arch. Toxicol."},{"issue":"10","key":"10.1016\/j.etap.2026.105022_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11100692","article-title":"Toxicometabolomics: small molecules to answer big toxicological questions","volume":"11","author":"Ara\u00fajo","year":"2021","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.etap.2026.105022_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.14117","article-title":"Epidemiology of new psychoactive substances in relation to traditional drugs of abuse in clinical oral fluid samples","volume":"136","author":"Axelsson","year":"2025","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.etap.2026.105022_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2023.111691","article-title":"Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances \u2013 a Swedish strategy to protect public health from harm","volume":"348","author":"B\u00e4ckberg","year":"2023","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.etap.2026.105022_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00204-013-1147-9","article-title":"\"Ecstasy\"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites","volume":"88","author":"Barbosa","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.etap.2026.105022_bib7","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.forsciint.2017.01.020","article-title":"Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series","volume":"273","author":"Barcel\u00f3","year":"2017","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.etap.2026.105022_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/1556-4029.14098","article-title":"Forty-three fatalities involving the synthetic cannabinoid, 5-fluoro-ADB: forensic pathology and toxicology implications","volume":"65","author":"Boland","year":"2020","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.etap.2026.105022_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-025-04074-4","article-title":"Discovering a predictive metabolic signature of drug-induced structural cardiotoxicity in cardiac microtissues","author":"Bowen","year":"2025","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.etap.2026.105022_bib10","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1038\/s41467-023-40333-7","article-title":"Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomics","volume":"14","author":"Bowen","year":"2023","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.etap.2026.105022_bib11","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1021\/acschemneuro.0c00644","volume":"11","author":"Cannaert","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"10.1016\/j.etap.2026.105022_bib12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nbt.2377","article-title":"A cross-platform toolkit for mass spectrometry and proteomics","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.etap.2026.105022_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12640-018-9924-0","article-title":"Cytotoxic effects of 3,4-catechol-PV (One Major MDPV metabolite) on human dopaminergic SH-SY5Y cells","volume":"35","author":"Coccini","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.etap.2026.105022_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.forsciint.2016.03.024","article-title":"Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines","volume":"264","author":"Couceiro","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.etap.2026.105022_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2017.12.015","article-title":"Metabolomics profiling of steatosis progression in HepaRG\u00ae cells using sodium valproate","volume":"286","author":"Cuykx","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"10","key":"10.1016\/j.etap.2026.105022_bib16","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s00204-018-2286-9","article-title":"vitro assessment of hepatotoxicity by metabolomics: a review","volume":"92","author":"Cuykx","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.etap.2026.105022_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.555372","article-title":"New insights on the role of N6-methyladenosine RNA methylation in the physiology and pathology of the nervous system","volume":"7","author":"Dermentzaki","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"6","key":"10.1016\/j.etap.2026.105022_bib18","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s12640-022-00601-8","article-title":"Neurotoxicity assessment of 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazine (LINS01 series) derivatives and their protective effect on cocaine-induced neurotoxicity model in SH-SY5Y cell culture","volume":"40","author":"Dos Santos","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.etap.2026.105022_bib19","unstructured":"European Union Drugs Agency. New psychoactive substances \u2013 the current situation in Europe (European Drug Report 2025). 2025. \u3008https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2025\/new-psychoactive-substances_en\u3009 (accessed 2025 June 16)."},{"issue":"58","key":"10.1016\/j.etap.2026.105022_bib20","doi-asserted-by":"crossref","first-page":"31048","DOI":"10.1007\/s11356-025-36789-3","article-title":"Presence of a synthetic cannabinoid, MDMB-INACA, in \u201cChimique\u201d in Mayotte: preliminary data on metabolism with a view to a future epidemiological study based on wastewater","volume":"32","author":"Gish","year":"2025","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"13","key":"10.1016\/j.etap.2026.105022_bib21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.etap.2026.105022_bib22","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/jat.3498","article-title":"Untargeted metabolomics of neuronal cell culture: a model system for the toxicity testing of insecticide chemical exposure","volume":"37","author":"Hayton","year":"2017","journal-title":"J. Appl. Toxicol."},{"issue":"4","key":"10.1016\/j.etap.2026.105022_bib23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/add.14868","article-title":"New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017","volume":"115","author":"Hondebrink","year":"2020","journal-title":"Addict. (Abingdon Engl.)"},{"key":"10.1016\/j.etap.2026.105022_bib24","series-title":"New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology","first-page":"495","article-title":"Fatal poisonings associated with new psychoactive substances","author":"Kronstrand","year":"2018"},{"issue":"2","key":"10.1016\/j.etap.2026.105022_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/dta.2935","article-title":"The next generation of synthetic cannabinoids: detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA","volume":"13","author":"Krotulski","year":"2021","journal-title":"Drug Test. Anal."},{"issue":"19","key":"10.1016\/j.etap.2026.105022_bib26","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/elps.201200605","article-title":"Mammalian cell metabolomics: Experimental design and sample preparation","volume":"34","author":"Le\u00f3n","year":"2013","journal-title":"Electrophoresis"},{"issue":"4","key":"10.1016\/j.etap.2026.105022_bib27","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00204-020-02693-7","article-title":"Designer drugs: mechanism of action and adverse effects","volume":"94","author":"Luethi","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.etap.2026.105022_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/metabo12010052","article-title":"Automated sample preparation and data collection workflow for high-throughput in vitro metabolomics","volume":"12","author":"Malinowska","year":"2022","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/j.etap.2026.105022_bib29","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00204-020-02742-1","article-title":"Toxicometabolomics of the new psychoactive substances \u03b1-PBP and \u03b1-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts","volume":"94","author":"Manier","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.etap.2026.105022_bib30","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00204-023-03474-8","article-title":"Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved","volume":"97","author":"Mart\u00ednez-Sena","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.etap.2026.105022_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/metabo11020097","article-title":"Untargeted metabolic profiling of 4-fluoro-furanylfentanyl and isobutyrylfentanyl in mouse hepatocytes and urine by means of LC-HRMS","volume":"11","author":"Montesano","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.etap.2026.105022_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01652-1","article-title":"Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey","volume":"11","author":"Moreno-Torres","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.etap.2026.105022_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0269881118812103","article-title":"Metabolomics predicts the pharmacological profile of new psychoactive substances","volume":"33","author":"Olesti","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.etap.2026.105022_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/toxsci\/kfaa015","article-title":"A targeted metabolomics-based assay using human induced pluripotent stem cell-derived cardiomyocytes identifies structural and functional cardiotoxicity potential","volume":"174","author":"Palmer","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.etap.2026.105022_bib35","article-title":"Characterization of neurotransmitter inhibition for seven cathinones by a proprietary fluorescent dye method","author":"Persson","year":"2023","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.etap.2026.105022_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1155271","article-title":"The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics","volume":"14","author":"Quint\u00e1s","year":"2023","journal-title":"Front Pharm."},{"issue":"12","key":"10.1016\/j.etap.2026.105022_bib37","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s00216-013-6798-0","article-title":"Liquid chromatography\/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening","volume":"405","author":"Roman","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.etap.2026.105022_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2025.104891","article-title":"Evaluation of THC-induced neurotoxicity via oxidative stress in undifferentiated SH-SY5Y cells","volume":"121","author":"Sanz-P\u00e9rez","year":"2026","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.etap.2026.105022_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","article-title":"Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics","volume":"24","author":"Schulz","year":"2020","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.etap.2026.105022_bib40","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/es5002105","article-title":"Identifying small molecules via high resolution mass spectrometry: communicating confidence","volume":"48","author":"Schymanski","year":"2014","journal-title":"Environ. Sci. Technol."},{"issue":"6","key":"10.1016\/j.etap.2026.105022_bib41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/toxres\/tfaa078","article-title":"vitro assessment of the cytotoxic, genotoxic and oxidative stress effects of the synthetic cannabinoid JWH-018 in human SH-SY5Y neuronal cells","volume":"9","author":"Sezer","year":"2020","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.etap.2026.105022_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115442","article-title":"S-(+)-Pentedrone and R-(+)-methylone as the most oxidative and cytotoxic enantiomers to dopaminergic SH-SY5Y cells: Role of MRP1 and P-gp in cathinones enantioselectivity","volume":"416","author":"Silva","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.etap.2026.105022_bib43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuropharm.2013.11.008","article-title":"Monoamine transporter and receptor interaction profiles of a new series of designer cathinones","volume":"79","author":"Simmler","year":"2014","journal-title":"Neuropharmacology"},{"issue":"13","key":"10.1016\/j.etap.2026.105022_bib44","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.3390\/ijms22136785","article-title":"Human neuronal cell lines as an in vitro toxicological tool for the evaluation of novel psychoactive substances","volume":"22","author":"Sogos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.etap.2026.105022_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuro.2021.05.009","article-title":"Metabolic profiling in human SH-SY5Y neuronal cells exposed to perfluorooctanoic acid (PFOA)","volume":"85","author":"Souders","year":"2021","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.etap.2026.105022_bib46","unstructured":"UNODC. World Drug Report 2025 - Contemporary issues on drugs. 2025. \u3008https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2025.html\u3009 (accessed 2025 September 9)."},{"key":"10.1016\/j.etap.2026.105022_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110470","article-title":"Navigating nitazenes: a pharmacological and toxicological overview of new synthetic opioids with a 2-benzylbenzimidazole core","volume":"275","author":"Vandeputte","year":"2025","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.etap.2026.105022_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109794","article-title":"Postmortem metabolomics as a high-throughput cause-of-death screening tool for human death investigations","volume":"27","author":"Ward","year":"2024","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.etap.2026.105022_bib49","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1007\/s12035-024-04614-6","article-title":"Mechanism of N6-methyladenosine modification in the pathogenesis of depression","volume":"62","author":"Xian","year":"2025","journal-title":"Mol. Neurobiol."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668926001006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668926001006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:34:22Z","timestamp":1780587262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668926001006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"alternative-id":["S1382668926001006"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2026.105022","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro metabolomics for the characterization of drugs of abuse and new psychoactive substances in SH-SY5Y cells","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2026.105022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105022"}}